(BIPH) Safeplus International - Ratings and Ratios
Exchange: NYSE • Country: USA • Currency: USD • Type: Common Stock •
BIPH: Medical Devices, Pacemakers, Neurostimulators, Photonics, Nanomaterials
Safeplus International Holdings Limited (NYSE:BIPH) is a company focused on developing and marketing advanced technologies for the medical device industry. Their portfolio includes innovations such as biothermal power supply, which could enable energy harvesting for medical devices, and pulsewidth modulation technology, designed to enhance the efficiency and performance of pacemakers and neurostimulators. Additionally, Safeplus holds patents in photonics and nanomaterials, which are crucial for miniaturization and performance improvement in medical devices. The company, founded in 1963 and headquartered in Pittsford, New York, is actively seeking partnerships to commercialize its technologies.
Technically, BIPHs stock shows a last price of $17.50, with a 20-day average volume of 10,550 shares. The SMA 20 and SMA 50 are both at $18.26, while the SMA 200 is slightly lower at $18.02, indicating recent price stability. The ATR of 0.42 suggests low volatility. On the fundamental side, the market cap is $0.36M USD, with a P/B ratio of 0.59 and P/S ratio of 0.96. The negative RoE of -1.74% reflects current financial challenges.
3-Month Forecast: Based on the technical data, BIPHs stock may face downward pressure as prices are below the SMA 20 and SMA 50. The low ATR indicates potential stability but limited upside. Fundamentally, the negative P/E and forward P/E suggest financial difficulties, which could impact investor sentiment. Investors should monitor these metrics closely for any shifts in the companys outlook.Additional Sources for BIPH Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
BIPH Stock Overview
| Market Cap in USD | 0m |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| GiC Sub-Industry | Health Care Equipment |
| IPO / Inception | 1999-11-26 |
BIPH Stock Ratings
| Growth 5y | -0.83% |
| Fundamental | 19.2% |
| Dividend | 66.3% |
| Rel. Strength Industry | -1.72 |
| Analysts | - |
| Fair Price Momentum | 17.41 USD |
| Fair Price DCF | - |
BIPH Dividends
| Dividend Yield 12m | 7.03% |
| Yield on Cost 5y | 6.26% |
| Annual Growth 5y | 13.52% |
| Payout Consistency | 99.0% |
BIPH Growth Ratios
| Growth Correlation 3m | 39.3% |
| Growth Correlation 12m | 57% |
| Growth Correlation 5y | -18.3% |
| CAGR 5y | -2.96% |
| CAGR/Max DD 5y | -0.08 |
| Sharpe Ratio 12m | -0.19 |
| Alpha | -7.70 |
| Beta | 0.38 |
| Volatility | 19.40% |
| Current Volume | 8.7k |
| Average Volume 20d | 10.6k |
As of March 14, 2025, the stock is trading at USD 17.84 with a total of 8,700 shares traded.
Over the past week, the price has changed by -0.17%, over one month by -3.25%, over three months by +3.98% and over the past year by -1.95%.
Neither. Based on ValueRay Fundamental Analyses, Safeplus International is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 19.17 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BIPH as of March 2025 is 17.41. This means that BIPH is currently overvalued and has a potential downside of -2.41%.
Safeplus International has no consensus analysts rating.
According to ValueRays Forecast Model, BIPH Safeplus International will be worth about 19 in March 2026. The stock is currently trading at 17.84. This means that the stock has a potential upside of +6.28%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 19 | 6.3% |